Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xeris Biopharma Holdings (XERS) Return on Invested Capital (2022 - 2024)

Historic Return on Invested Capital for Xeris Biopharma Holdings (XERS) over the last 4 years, with Q2 2025 value amounting to 0.05%.

  • Xeris Biopharma Holdings' Return on Invested Capital rose 1300.0% to 0.05% in Q2 2025 from the same period last year, while for Jun 2025 it was 0.05%, marking a year-over-year increase of 1300.0%. This contributed to the annual value of 0.17% for FY2024, which is 400.0% up from last year.
  • As of Q2 2025, Xeris Biopharma Holdings' Return on Invested Capital stood at 0.05%, which was up 1300.0% from 0.11% recorded in Q1 2025.
  • Xeris Biopharma Holdings' Return on Invested Capital's 5-year high stood at 0.05% during Q2 2025, with a 5-year trough of 0.61% in Q1 2022.
  • Moreover, its 4-year median value for Return on Invested Capital was 0.24% (2023), whereas its average is 0.29%.
  • In the last 5 years, Xeris Biopharma Holdings' Return on Invested Capital surged by 3200bps in 2023 and then soared by 300bps in 2024.
  • Quarter analysis of 4 years shows Xeris Biopharma Holdings' Return on Invested Capital stood at 0.38% in 2022, then soared by 40bps to 0.23% in 2023, then increased by 27bps to 0.17% in 2024, then soared by 73bps to 0.05% in 2025.
  • Its Return on Invested Capital stands at 0.05% for Q2 2025, versus 0.11% for Q1 2025 and 0.17% for Q4 2024.